LING, HUAZHENG – Trademark Portfolio

Entity Type: 01

LING, HUAZHENG holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 7 (Machinery) — 1 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include TMUT. The owner is based in HANGZHOU, ZHEJIANG.

1003, UNIT 3, BUILDING 1, LANJUE

INTERNATIONAL CENTER BEIGAN STREET, XIAOSHAN DISTRICT

HANGZHOU, ZHEJIANG 310000 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

AOLEMON
AOLEMON
Abandoned 2024
TMUT
TMUT
Registered 2020

Trademark Classifications

LING, HUAZHENG's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

7
Machinery (1 filing)

Machines and machine tools; motors and engines; machine coupling and transmission components

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does LING, HUAZHENG have?

LING, HUAZHENG has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned.

What trademark classes does LING, HUAZHENG file in?

LING, HUAZHENG files trademarks across 2 Nice Classification classes. The most active classes are Class 7 (Machinery), Class 10 (Medical Apparatus). Class 7 covers machines and machine tools; motors and engines; machine coupling and transmission components.

What are LING, HUAZHENG's most well-known trademarks?

LING, HUAZHENG's registered trademark portfolio includes well-known marks such as TMUT. These are among 1 currently registered trademark in the portfolio.

What is LING, HUAZHENG's trademark registration success rate?

LING, HUAZHENG has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.